Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors

References

1. ↵
   Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541–548

   PubMedWeb of Science
2. ↵
   Segebarth CM, Baleriaux DF, Luyten PR, den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging. Magn Reson Med 1990;13:62–76

   PubMedWeb of Science
3. ↵
   Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675–686

   PubMed
4. Baker PB, Glickson JD, Brayn RN. In vivo magnetic resonance spectroscopy of human brain tumors. Top Magn Reson Imaging 1993;5:32–45

   PubMed
5. ↵
   Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593–1603

   Abstract
6. ↵
   Castillo M, Kwock L, Mukherji SK. Clinical applications of MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15

   PubMedWeb of Science
7. Krouwer HGJ, Kim TA, Rand SD, et al. Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. AJNR Am J Neuroradiol 1998;19:1695–1703

   Abstract
8. ↵
   Castillo M, Kwock L. Proton MR spectroscopy of common brain tumors. Neuroimaging Clin North Am 1998;8:733–752
9. ↵
   Meyerand ME, Pipas JM, Mamourian A, Tosteson TD, Dunn JF. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol 1999;20:117–123

   Abstract/FREE Full Text
10. Nelson SJ, Vigneron DB, Dillon WP. Serial evaluation of patients with brain tumors using volume MRI and 3D 1-H MRSI. NMR Biomed 1999;12:123–128

    CrossRefPubMed
11. ↵
    Castillo M, Kwock L. Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. Top Magn Reson Imaging 1999;10:104–113

    PubMed
12. Grand S, Passaro G, Ziegler A, et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1-H MR spectroscopy—initial results. Radiology 1999;213:785–793

    CrossRefPubMedWeb of Science
13. ↵
    Burtscher IM, Skagerberg G, Geijer B, Englund E, Ståhlberg F, Holtås S. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 2000;21:84–93

    Abstract/FREE Full Text
14. ↵
    Shimizu H, Kumabe T, Shirane R, Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 2000;21:659–665

    Abstract/FREE Full Text
15. ↵
    Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645–1649

    Abstract/FREE Full Text
16. ↵
    Bendszus M, Warmuth-Metz M, Klein R, et al. MR spectroscopy in gliomatosis cerebri. AJNR Am J Neuroradiol 2000;21:375–380

    Abstract/FREE Full Text
17. ↵
    Butzen J, Prost R, Chetty V, et al. Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with logical regression model. AJNR Am J Neuroradiol 2000;21:1213–1219

    Abstract/FREE Full Text
18. ↵
    Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed 2001;14:339–349

    CrossRefPubMedWeb of Science
19. ↵
    Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001;22:604–612

    Abstract/FREE Full Text
20. ↵
    Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001;22:1316–1324

    Abstract/FREE Full Text
21. Tzika AA, Cheng LL, Goumnerova L, et al. Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. J Neurosurg 2002;96:1023–1031

    PubMed
22. ↵
    Tzika AA, Zarifi MK, Goumnerova L, et al. Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. AJNR Am J Neuroradiol 2002;23:322–333

    Abstract/FREE Full Text
23. ↵
    Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371–381

    CrossRefPubMedWeb of Science
24. ↵
    Sener RN. Longstanding tectal tumors: proton MR spectroscopy and diffusion MRI findings. Comput Med Imaging Graph 2002;26:25–31

    PubMed
25. ↵
    Krabbe K, Gideon P, Wang P, Hansen U, Thomsen C, Madsen F. MR diffusion imaging of human intracranial tumors. Neuroradiology 1977;39:483–489
26. ↵
    Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–407

    PubMedWeb of Science
27. ↵
    Hajnal JV, Doran M, Hall AS, et al. MR imaging of anisotropically restricted diffusion of water in the nervous system: technical, anatomic, and pathologic considerations. J Comput Assist Tomogr 1991;15:1–18

    PubMedWeb of Science
28. ↵
    Tien RD, Felsberg GJ, Friedman H, Brown M, MacFall J. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 1994;162:671–677

    PubMedWeb of Science
29. ↵
    Brunberg JA, Chenevert TL, McKeever PE, et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 1995;16:361–371

    Abstract/FREE Full Text
30. ↵
    Noguchi K, Watanabe N, Nagayoshi T, et al. Role of diffusion-weighted echo-planar MRI in distinguishing between brain abscess and tumour: a preliminary report. Neuroradiology 1999;41:171–174

    CrossRefPubMed
31. ↵
    Stadnik TW, Chaskis C, Michotte A, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001;22:969–976

    Abstract/FREE Full Text
32. ↵
    Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081–1088

    Abstract/FREE Full Text
33. ↵
    Filippi CG, Edgar MA, Uluǧ AM, Prowda JC, Heier LA, Zimmerman RD. Appearance of meningiomas on diffusion-weighted images: Correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 2001;22:65–72

    Abstract/FREE Full Text
34. ↵
    Le Bihan D, Douek P, Argyropoulou M, Turner R, Patronas N, Fulham M. Diffusion and perfusion magnetic resonance imaging in brain tumors. Top Magn Reson Imaging 1993;5:25–31

    PubMed
35. Eis M, Els T, Hoehn-Berlage M, Hossman KA. Quantitative diffusion MR imaging of cerebral tumor and edema. Acta Neurochir Suppl (Wien) 1994;60:344–346

    PubMed
36. ↵
    Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2001;22:60–64

    Abstract/FREE Full Text
37. ↵
    Maier SE, Bogner P, Bajzik G, et al. Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging. Radiology 2001;219:842–849

    CrossRefPubMedWeb of Science
38. ↵
    Sinha S, Bastin ME, Whittle IR, Wardlaw JM. Diffusion tensor MR imaging of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2002;23:520–527

    Abstract/FREE Full Text
39. ↵
    Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715–721

    PubMedWeb of Science
40. ↵
    Sijens PE, Knopp MV, Brunetti A, et al. H-1 spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 1995;33:818–826

    CrossRefPubMedWeb of Science
41. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449–458

    CrossRefPubMedWeb of Science
42. Pruel MC. Accurate noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med 1996;2:323–325

    CrossRefPubMedWeb of Science
43. Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516–524

    PubMedWeb of Science
44. ↵
    Rand SD, Prost R, Haughton V, et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from non-neoplastic brain lesions. AJNR Am J Neuroradiol 1997;18:1695–1704

    Abstract
45. ↵
    Remy C, Grand S, Lai ES, et al. 1H MRS of human brain abscesses in vivo and in vitro. Magn Reson Med 1995;34:508–514

    PubMed
46. ↵
    Gupta RK, Vatsal DK, Husain N, et al. Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol 2001;22:1503–1509

    Abstract/FREE Full Text
47. ↵
    Jayasundar R, Singh VP, Raghunathan P, Jain K, Banerji AK. Inflammatory granulomas: evaluation with proton MRS. NMR Biomed 1999;12:139–144

    CrossRefPubMedWeb of Science
48. ↵
    Lee DY, Chung CK, Hwang YS, et al. Dysembryoplastic neuroepithelial tumor: radiological findings (including PET, SPECT, and MRS) and surgical strategy. J Neurooncol 2000;47:167–174

    CrossRefPubMed